Skip to search formSkip to main contentSkip to account menu

Evoxac

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Cevimeline (Evoxac ®) is an oral muscarinic agent that has been recently approved for the treatment of xerostomia in the setting… 
2009
2009
OBJECTIVE The aim of the present study was to compare the effect of low-dose pilocarpine and cevimeline as stimulants for… 
Review
2007
Review
2007
M1 muscarinic receptors (M1 mAChRs) play a role in an apparent linkage of three major hallmarks of Alzheimer’s disease (AD… 
2007
2007
Muscarinic M3 receptors exist in the gastrointestinal wall in humans and the muscarinic M3 agonist cevimeline hydrochloride… 
2004
2004
Irrigation of the salivary gland using a corticosteroid is one of the most successful approaches to improving xerostomia in… 
2002
2002
The M1 muscarinic agonists AF102B (Cevimeline, EVOXACTM: prescribed in USA and Japan for Sjogren’s Syndrome), AF150(S) and AF267B… 
2000
2000
  • The Medical letter on drugs and therapeutics
  • 2000
  • Corpus ID: 19365988